
1 - 10 employees
Founded 2017
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $100M Private Equity Round on 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
Selected: 🆕 Date Added.
🔥 6 hours ago
Executive Director leading bioanalytical strategy, assays, teams, and external partners at Dianthus Therapeutics. Supporting autoimmune therapy research, clinical development, and regulatory submissions.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 11%
🕒 August 19
Associate Director guiding QSP, PopPK, and exposure-response modeling for Dianthus Therapeutics’ autoimmune and neuromuscular therapies. Supporting dose selection, formulation bridging, and regulatory strategy.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 11%
🕒 August 19
Associate Director overseeing global clinical trial operations for Dianthus Therapeutics’ autoimmune disease therapies. Driving study strategy, execution, compliance, and resource management across clinical programs.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
🏥 Clinical Operations
👻 Ghost score 11%
🕒 July 22
Director/Senior Director, Program Management overseeing inter-disciplinary drug development programs at Dianthus Therapeutics. Collaborating with scientists and stakeholders to develop strategies and deliver results.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👷♀️ Project Manager
👻 Ghost score 16%
🕒 July 6
Associate Director/Director leading external manufacturing for CMC of drug products at Dianthus Therapeutics. Focusing on monoclonal antibodies and ensuring compliance with regulatory standards.
🇺🇸 United States – Remote
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 20%